Demographic and clinical data for arthritic patients and controls. Values are mean ± SD.
| Characteristic | Control (n = 25) | RA < 65 (n = 25) | Sample Type RA > 65 (n = 24) | AS (n = 27) | PsA (n = 23) | OA (n = 17) |
|---|---|---|---|---|---|---|
| Age, yrs | 51.1 ±6.1 | 54.4 ± 6.7 | 71.7 ± 5.6* | 51.4 ± 9.7 | 53.5 ± 8.8 | 68.7 ± 9.6* |
| Men/women | 10/15 | 6/19 | 6/18 | 12/20 | 11/12 | 5/12 |
| Disease duration, yrs | 13.2 ± 9.3 | 16.9 ± 10.9 | 8.9 ± 9.1 | 9.9 ± 7.2 | ||
| DAS28 | 5.6 ± 1.1 | 5.7 ± 1.3 | 4.3 ± 1.6 | |||
| Larsen score | 2.7 ± 1.0 | 3.4 ± 0.8* | ||||
| BASDAI | 58.5 ± 21.0 | 57.7 ± 25.8 | ||||
| BASFI | 55.4 ± 25.8 | 56.2 ± 25.1 | ||||
| Sacroiliitis | 2.7 ± 1.1 | 2.7 ± 0.5 | ||||
| Lequesne index | 13.0 ± 2.8 |
RA patients were divided into 2 subgroups by age: < 65 and > 65 yrs.
↵* Statistically significant difference vs other groups for age and vs RA < 65 for Larsen score. RA: rheumatoid arthritis; AS: ankylosing spondylitis; PsA: psoriatic arthritis; OA: osteoarthritis.